Hyaluronic acid, Xeljanz studies top week's dermatology reads

Study results finding that full-facial volume restoration was sustained over 18 months in patients who received hyaluronic acid filler with lidocaine was the most read-article of the past week on Healio.com/Dermatology.

Other widely read articles included study results finding that patients with severe nail dystrophy related to alopecia universalis who were treated with Xeljanz experienced normal nail growth:

Full-facial volume restoration sustained over 18 months with hyaluronic acid filler

Full-facial volume restoration was sustained over 18 months in patients who received hyaluronic acid filler with lidocaine, according to recently published study results.

Researchers studied 60 patients (54 women; mean age, 53.5 years) between February 2012 and March 2013 at four centers in Brazil. Read more

Xeljanz effectively treated nail dystrophy in patients with alopecia universalis

Patients with severe nail dystrophy related to alopecia universalis who were treated with Xeljanz experienced normal nail growth, according to study results recently published in JAMA Dermatology.

“Nail dystrophy in [alopecia areata] and variants is common, affecting 7% to 66% of patients, and includes nail pitting, trachyonychia, onychorrhexis, red spotting of the lunulae, onycholysis, onychomadesis and Beau lines,” Arjun Dhayalan, BS, and Brett A. King, MD, PhD, wrote. Read more

BioPharmX reports BPX-01 topical minocycline safely treats acne

BioPharmX Corp. announced that research shows its topical minocycline formula safely delivers the antibiotic to a layer of skin where acne develops.

Results will be presented at the American Society of Cell Biology annual meeting regarding the treatment with BPX-01, the only stable topical hydrophilic topical gel with fully solubilized minocycline, according to a press release. Read more

Online reviews gauge patient satisfaction at dermatology practices

A broad range of factors determined outpatients’ experiences at dermatology practices, according to an analysis of two consumer reporting websites.

Researchers at the University of Pennsylvania conducted a qualitative analysis of patient-generated reviews of dermatology practices on Yelp, a consumer review platform for businesses; and ZocDoc, a physician scheduling and review website. Read more

Insurance status associated with outcomes with melanoma

Patients with malignant melanoma who were uninsured or on Medicaid were more likely to present with advanced disease and less likely to receive treatment, which likely contributed to worse survival when compared with patients with non-Medicaid insurance, according to study results.

Researchers used the Surveillance, Epidemiology and End Results (SEER) database to conduct a cross-sectional analysis of 61,650 patients (median age, 52 years) diagnosed with cutaneous malignant melanoma between 2007 and 2012. Read more